The malaria diagnostics market value is expected to reach US$ 1,200.24 million by 2030 from US$ 782.57 million in 2022.

The report highlights trends in the market and factors driving and hindering the growth of the malaria diagnostics market.

Malaria awareness campaigns help enhance the population's knowledge of the disease, promoting healthcare services through intersectoral collaboration and social support. The WHO coordinates with the Global Malaria Programme (GMP) as part of its efforts to control and eradicate malaria worldwide. The organization observes World Malaria Day on April 25 of every year to highlight the communities' commitment to spreading awareness about malaria (disease, prevention, diagnostics, treatment, etc.).

Governments of several countries are taking various initiatives to conduct research for the development of new antimalarial drugs and vaccines. As per the WHO data, total funding for the control and elimination of malaria reached ~US$ 3 billion in 2019; the governments of endemic regions such as Africa and Asia collectively contributed 31% (~US$ 900 million) of the total funding to create awareness and development of new vaccines for the treatment of the disease. Various private companies are investing heavily in R&D activities to reduce the incidence of malaria. According to the Global Health Policy, the US government allocated ~US$ 1 billion in FY 2022 for malaria control and research activities. Under the PMI Strategy 2021-2026, the US government aims to control the spread of malaria and reduce deaths caused by it, with a long-term aim of eradicating the disease.

Governments of various countries across the globe are deploying several strategies to eliminate the disease by improving access to healthcare services, including treatment options, to the people.

- Myanmar has a national malaria control plan approved by the Global Fund. By 2030, it is expected to eliminate the disease caused by P. falciparum. The universal healthcare coverage in the country also includes access to malaria diagnosis through microscopy or rapid diagnostic tests (RDTs) and artemisinin-based combination therapies (ACTs).

- The government of Thailand has implemented a National Malaria Elimination Strategy (NMES) 2017-2026 that further applies an integrated elimination strategy against the disease.

- In January 2020, the Corporate Alliance on Malaria in Africa (CAMA) launched a strategic plan for 2021-2023 to reach millions of people through malaria control interventions, thereby scaling up prevention activities in Africa.

Thus, such efforts to propel community engagement reinforce the eradication measures and bolster the growth of the malaria diagnostics market.

The malaria diagnostics market, by technology, is segmented into microscopy, rapid diagnostic tests (RDTs), and molecular diagnostic tests. The rapid diagnostic tests (RDTs) segment held the largest share of the market in 2022 and is projected to register the highest CAGR during 2022-2030. Malaria rapid diagnostic tests (RDTs) aid in diagnosing malaria by demonstrating the presence of malaria parasites in human blood. Rapid diagnostic tests (RDTs) are increasingly being used to diagnose malaria. RDTs are quick and simple and do not require electricity or specialized equipment. There are currently 28 distinct manufacturers offering 86 different malaria RDTs. Microscopy continues to be a crucial tool in malaria research studies and diagnosis. It is expected to remain relevant in drug efficacy monitoring as the initial signs of resistance to antimalarial drugs are commonly seen through a reduced parasite clearance rate.

The malaria diagnostics market, by end-user, is segmented into hospitals and clinics, diagnostic centers, and others. The hospitals and clinics segment held the largest market share in 2022. hospitals and clinics provide enhanced care services to community members and support primary care. The malaria diagnostics market for the hospitals and clinics segment is driven by growing public-private partnerships in the healthcare sector and the increasing incidences of malaria. The rapidly evolving hospital and clinic industry is changing the face of this sector. The hospitals and clinics are backed by specialized infrastructure and medical personnel specialized in providing quality care, which would continue to drive the market growth for this segment in the coming years. Further, the growing emphasis on using RDTs for their rapid turnaround times, low costs, and convenient accessibility is one of the main causes of the dominance of clinics in the malaria diagnostics market.

World Health Organization and Centers for Disease Control and Prevention (CDC) are key primary and secondary sources mentioned while preparing the report on the malaria diagnostics market.